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ABSTRACT 
Jackson Luke Carver: Feasibility Study of a Home-based Exercise Intervention Program for 
Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Androgen-Deprivation 
Therapy 
(Under supervision of Erik Hanson) 
 
Purpose: To assess the feasibility of home-based exercise in men with metastatic castration-
resistant prostate cancer (mCRPC) receiving androgen deprivation therapy (ADT). Methods: Men 
with mCRPC undergoing ADT completed body composition, muscular function, physical 
function, and cardiorespiratory fitness assessments before and after a 12-week home-based 
exercise intervention. Adherence to the intervention was monitored using a Garmin vivosmart HR 
device. Changes in fitness parameters were assessed using paired-samples t-tests. Results: Of the 
10 men who completed baseline testing, 70% completed post-testing. Each of these men adhered 
to greater than 75% of planned walking and resistance training sessions. Significant improvements 
were found in lower body strength (p=0.023) and cardiorespiratory fitness (p=0.013). Conclusion: 
A home-based exercise intervention appears to be feasible in men with mCRPC undergoing ADT.  
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CHAPTER I: INTRODUCTION 
  
Cancer 
Cancer is the second leading cause of death in the United States (following cardiovascular 
disease) and is projected to become the number one cause of death by 2020 (Herron 2016). Nearly 
40% of people in the United States are expected to be diagnosed with cancer at some point in their 
lifetime. While death rates and age-adjusted incidence for most types of cancer have been 
declining, the number of new cancer diagnoses each year of most forms of cancer are projected to 
increase with an aging population (Weir 2015). More people are now living with cancer than ever 
before. This has created a new challenge for oncologists and researchers to find ways to alleviate 
negative side effects of life-saving treatments for cancer patients. 
 Prostate cancer (PCa) is the most commonly diagnosed form of cancer among men 
in the United States and is a prime example of living longer with cancer. It is projected that one-
in-five new cancer diagnoses in 2018 will be PCa, but PCa will only result in 9% of cancer-related 
deaths among men (Siegel, 2018). While one in seven men in the United States are expected to be 
diagnosed with PCa, only one in every thirty-nine men will die as a direct result of it (Siegel, 
2018). One of the core treatments for PCa is androgen deprivation therapy (ADT). ADT is effective 
because PCa tumors are androgen-dependent, at least initially (Jung Kang Jin 2011), however there 
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are several adverse effects that include loss of lean mass (Hanson 2011, Galvao 2008, Grossman 
2011, Smith 2012) female-pattern fat distribution (Hanson 2011, Galvao 2008, Grossman 2011, 
insulin resistance (Hanson 2011, Grossman 2011) chronic fatigue (Hanson 2011, Grossman 2011), 
and loss of physical function (Hanson 2011, Galvao 2008, Grossman 2011). As the disease 
progresses (mean of 2-3 years after onset of ADT) (Karantanos 2013), tumors metastasize and 
often become “castration resistant,” and will grow despite the lower levels of circulating androgens 
(Jung Kang Jin 2011). This indicates a worse prognosis for the patient and a mean survival time 
between 16 and 18 months (Amaral 2012). The standard of care for castration-resistant prostate 
cancer (CRPC) and metastatic castration-resistant prostate cancer (mCRPC) involves a secondary 
form of androgen deprivation, sometimes called “super castration,” (Pezaro 2013) which almost 
completely limits production of endogenous androgens or androgen receptors and limits 
intratumoral androgen activity that sustains the tumor cells (Karantanos 2013, Jung Kang Jin 
2011). This may limit disease progression, but may also exacerbate the side effects of ADT 
promoting dramatic negative effects on body composition, increasing risk factor profile for the 
development of cardiovascular and metabolic disease; all impacting the quality of life (QoL) of 
the patient (Pezaro 2013, Wall 2015). As ADT is often used indefinitely, patients will be affected 
by these side effects of treatment for the remainder of their lives. With men living longer while 
undergoing treatments such as ADT, finding ways to alleviate the struggles associated with 
survivorship are paramount.  
Exercise in PCa 
Exercise has been studied as one potential mechanism of improving patient outcomes 
affected by ADT and is promoted in current cancer survivorship guidelines published by the 
American Cancer Society and American College of Sports Medicine (Zopf 2014, Schmitz 2010). 
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Resistance training, has been shown to have a positive effect on lean mass, body composition, 
strength, level of fatigue, and physical function in men with PCa on ADT (Galvao 2006, w, Hanson 
2013, Hanson 2011, Hanson 2016, Tomlinson 2014). It is clear that resistance training is beneficial 
to PCa survivors, particularly improving measures which decline as a result of ADT. There is also 
evidence that aerobic exercise can be beneficial to PCa patients, offering unique benefits aside 
from those associated with resistance training (particularly improving cardiorespiratory fitness) 
(Galvao 2010, Wall 2017). PCa patients stand to gain a variety of benefits from a combined 
exercise program. Recent evidence has also arisen that has shown that these benefits can be 
achieved even in later stages of disease. Cormie et al (2013) recently found resistance training to 
be safe and well-tolerated in PCa patients with bone metastases, a population in which exercise 
has been relatively contraindicated due to potential risk for fractures and skeletal injury. In addition 
to being well-tolerated, the exercise-group also showed gains in strength (11%), 6-m rapid and 
usual walk times (12%), and lean mass (3%). This study provides evidence that an exercise 
intervention can safely offer significant benefits to patients with advanced disease (who may be in 
the most need of exercise-related health benefits). Galvao (2017) has also provided evidence that 
exercise provides many of the same benefits in men with CRPC, opening the door for further 
exploration into exercise interventions in this population that are more feasible to patients who are 
unable to participate in supervised in-center programs. 
 A recent review of the effects of resistance training in cancer survivors has 
concluded that, while strength training does have a positive impact in the lives of patients with 
several forms of cancer, there are still gaps that need to be filled before strength training can be 
used as a physician-recommended therapy (Hanson 2016). One reason for this is because of the 
relative difficulty to provide effective, feasible exercise prescriptions to patients with significant 
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barriers to exercise, particularly those with mCRPC. Many exercise interventions can be difficult 
or impossible for patients to complete due to needs for equipment, travel, or supervision (Sheill 
2018, Clifford 2017). Aside from the benefits of the exercise intervention alone, there is evidence 
that PCa patients dramatically reduce their level of physical activity as their disease progresses, 
creating a “vicious cycle” in which the avoidance of physical activity leads to further decreases in 
QoL and physical function (Hanson 2011). Thus, finding an effective exercise program for 
mCRPC patients to follow is critical to maximizing patient physical function and QoL across the 
remainder of the lifespan. 
Study Rationale and Purpose 
 Because exercise may be particularly burdensome to patients with mCRPC because of 
both the disease and side effects of treatment, it is important that exercise programs avoid adding 
additional burden while still being effective at improving their health. It is also important to 
develop programs which are available to the majority of mCRPC patients and are feasible to 
complete. One proposed solution to these problems is using home-based exercise, which has been 
successfully used in breast cancer survivors (Spector 2014). Home-based exercise may be an 
effective solution for mCRPC patients that otherwise do not have access to resources required for 
other exercise programs and may also give the patient more freedom as to when to complete the 
exercise. Currently, as no home-based exercise interventions have been performed in these 
patients, it is unclear as to whether a home-based exercise program is feasible for men with 
mCRPC.  
Therefore, the purpose of this study was to assess the feasibility of a home-based exercise 
program in men with mCRPC. Our primary objectives of this feasibility study were to investigate 
if men with mCRPC on ADT would 1) enroll in a 12 week, home-based exercise program offered 
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to them, and 2) to determine the completion rates. A secondary objective was to examine changes 
in body composition, strength, physical function, aerobic capacity, QoL, depression, and fatigue 
before and after the exercise intervention. 
Research Questions 
1. What percentage of mCRPC patients undergoing ADT that are eligible and asked to 
participate in a 12-week home-based combined resistance training and aerobic exercise 
program will enroll in the program? 
2. What percentage of mCRPC patients undergoing ADT who complete baseline testing will 
adhere to at least 75% of the prescribed exercise sessions and complete post-testing at the 
end of the intervention? 
3. Does a 12-week combined resistance and aerobic exercise program produce any 
improvements in body composition, strength, physical function, aerobic capacity, QoL, 
depression, or fatigue? 
Research Hypotheses 
1. The research team will be able to recruit fifteen mCRPC patients undergoing ADT referred 
to a free 12-week combined resistance and aerobic exercise program will enroll. 
2. Greater than two thirds (67%) of participants who enroll in a 12-week combined resistance 
and aerobic exercise program will adhere to at least 75% of the prescribed exercise sessions 
complete baseline and post-testing. 
3. A 12-week combined resistance and aerobic exercise program will result in positive 
changes in, strength, physical function, aerobic capacity, QoL, depression, and fatigue, 
while maintain body composition. 
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Limitations  
1. The use of multiple exercise tests per session may result in less-than-maximal 
performance on some tests, though the order of the tests were arranged to minimize this 
effect. 
2. There is no control group in this study. 
3. Participants cannot be monitored during their resistance training sessions. 
Delimitations 
1. Participants completed all baseline and post-intervention tests in a single session in 
order to limit participant burden and encourage participation. 
2. Only mCRPC patients undergoing ADT with total testosterone < 50 ng/dl will be 
eligible to participate. 
Significance 
 This study provides insight into the adherence of a home-based exercise program 
by men with mCRPC. If home-based exercise program proves to be feasible in this population, 
other exercise interventions may be designed to target specific physiological deficits that occur 
with ADT in these patients. This study provides the research team with the opportunity to speak 
with the subjects weekly to improve adherence and to assess barriers that may have hindered 
successful completion of the program. While a few studies examining exercise interventions in 
this metastatic prostate cancer patients (Cormie 2013, Galvao 2017), this study expands current 
knowledge by utilizing a home-based approach in patients with advanced disease. The 
information related to feasibility, adherence, and ultimately the ability to alter physical and 
psychological parameters is a crucial first step in designing effective of exercise interventions for 
this population in the future
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CHAPTER 2: REVIEW OF THE LITERATURE 
 
Cancer 
 Cancer survivorship has become a popular field of research, and the demand for 
this research is likely going to continue to increase. The prognosis for the average cancer patient 
has improved substantially in the past four decades due to improvements in earlier detection and 
different treatment options (Carver 2007, Siegel 2018). This has allowed patients to live longer, 
with the majority of cancer patients now living more than five years beyond their initial diagnosis. 
Both cancer and many of the therapies used to treat cancer have deleterious effects on 
cardiovascular and metabolic health, often leading to the development of comorbidities that have 
significant damaging impacts on the patient’s quality of life (Kushi 2012, Siegel 2018). These 
comorbidities may also lead to recurrence of the cancer or the development of other chronic 
illnesses (Kushi 2012). Aside from these comorbidities, an overwhelming majority of cancer 
survivors will experience fatigue and a decreased QoL (Stone 2008). Survivorship is important not 
only because patients are living longer, but also because the number of new cancer diagnoses of 
all forms of cancer are expected to increase with an aging population (Movsas 2012, Siegel 2018). 
The number of cancer cases is projected to be over 20% greater for both men and women in 2020 
than in 2010 (Movasas 2012, Weir 2015), despite incidence rates remaining relatively constant. 
By 2030, one in five people in the United States will be over the age of 65, and these people will 
represent 70% of all cancer patients (Movsas 2012).  The need for strong guidelines and therapies 
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for cancer survivors to maintain quality of life and physical function is paramount, and will only 
increase over the foreseeable future. 
Prostate Cancer (PCa) 
 Over 164,000 men are expected to be diagnosed with PCa in 2018 alone, accounting 
for almost one fifth of all new cancer diagnoses among men in 2018 (Siegel 2018). While PCa 
incidence has been rapidly decreasing since 2008, this has been largely attributed to changes in 
prostate specific antigen (PSA) testing guidelines (Siegel 2018). Even with this sharp decline, PCa 
still has been the most common malignant cancer diagnosed among men, and the number of PCa 
survivors in the United States will continue to grow for years to come. A number of treatments 
have been developed for PCa, allowing for PCa patients to live longer than people with many other 
types of cancer. Common PCa treamtents include hormone therapy (ADT), chemotherapy, 
radiation therapy, and prostatectomy. Most patients will undergo multiple forms of treatment over 
the course of the disease, with some therapies (particularly ADT) being a recurring part of the 
patient’s treatment plan. Because of this, the relative stage of PCa is often characterized by its 
responsiveness to hormone therapy (recurring elevations in PSA level despite ADT result in the 
disease being labeled CRPC). 
 While the number of new PCa cases have been increasing, mortality rates have been 
decreasing since 1970. In the United States, PCa five-year survival rates are above 99% until 
distant metastases have formed, when five-year survival drops to roughly 30% (Sigel 2018). A 
recent retrospective study by Moreira et al found median times from PCa diagnosis to ADT, ADT 
to CRPC were 0.7 and 3.6 years respectively (Moreira 2016). The same study found that one third 
of patients had a time from CRPC diagnosis to metastases detection greater than five years. These 
results provide perspective on the length of time in which PCa survivors will be living with disease 
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and treatment side effects for each stage of the disease. As PCa continues to be detected earlier 
and treatment plans become more aggressive from the time of diagnosis, managing side effects of 
these aggressive treatments will become increasingly important to maximize patient QoL. 
ADT 
ADT is one of the core treatments used for PCa and includes a variety of drugs to block 
androgen production or androgen receptor function. PCa tumors are initially dependent upon 
androgens to progress and are considered “hormone sensitive.” ADT has been shown to improve 
patient survival time, and it is often used indefinitely in the United States (Merseburger 2015, 
Ludwig 2015). In fact, ADT remains a staple therapy even after the disease has progressed to its 
hormone insensitive state, and indefinite use of ADT is even more common in these patients (Jung 
Kang Jin 2011, Merseburger 2015). It has recently been found that tumor progression in this state 
is largely due to an upregulation of intratumoral androgen signaling, allowing further proliferation 
(Jung Kang Jin 2011, Karantanos 2013). There are several proposed mechanisms in which this 
occurs, but it is not yet completely understood. ADT in this stage is a palliative treatment, and 
advancement to CRPC is considered inevitable in the progression of the disease. 
ADT, like other cancer therapies, is not without its side effects. These side effects are well 
documented and include negative changes in lean mass, strength, muscular endurance, physical 
function, resting metabolic rate, cardiopulmonary capacity, fat mass, bone mass, insulin 
sensitivity, sexual performance, and QoL (Hanson 2011, Grossman 201, Galvao 2008, Hurley 
2011, Pezaro 2013, Wall 2015). Aside from these, ADT may lead to increased risk for 
cardiovascular disease and diabetes mellitus (Basaria 2008, Essien 2016, Haque 2017, Grossman 
2011), though the evidence is inconclusive (Basaria 2012, Levine 2011, Zareba 2016). This could 
possibly due to difficulties attributing cardiovascular events to ADT versus age-related events in 
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age-matched healthy men and heterogeneity between ADT duration and pre-exiting cardiovascular 
disease in patients between studies (Zareba 2016). Furthermore, the recent development of ADT 
medications (such as abiraterone or enzalutamide) that can reduce circulating testosterone levels 
to “super-castration” levels leads to more dramatic side effects related to androgen deprivation. 
For example, Pezaro et al (2013) found that men beginning abiraterone therapy experienced a mean 
percent loss in muscle mass between 2.8% and 4.3% (depending on BMI) in the first six months 
of treatment with abiratrone, which occurred after previous ADT or surgical castration. Smith and 
colleagues (2012) found that other medications Given that medications such as abiraterone are 
becoming more widely used earlier in treatment (Rove 2014) and their potential indefinite use 
(well beyond six months), it is clear that there will be an increase in an already strong demand for 
ways to mitigate losses in lean mass and physical function in PCa survivors. 
Nutrition and Physical Activity Guidelines for Cancer Patients 
The American Cancer Society established guidelines for nutrition and physical activity in 
cancer survivors in 2012 (Schmitz 2010, Rock 2012). The guidelines are an important and helpful 
resource for cancer patients looking to maintain their functional status and health, but the 
guidelines concede that optimal lifestyle behaviors and treatments can vary substantially between 
patients. The guidelines recommend cancer patients be physically active, control their weight, and 
maintain a healthy diet. These guidelines are in accordance with the guidelines set by the American 
College of Sports Medicine, recommending 150 minutes of exercise (ACSM specifies moderate-
intensity) and at least two resistance training sessions per week. While the guidelines provide 
useful information and valuable insights as to how to maintain a healthy lifestyle, it is apparent 
(and stated in the guidelines) that more work needs to be done to create concrete nutrition and 
physical activity guidelines for these patients, particularly with the expected increase in number of 
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cases in the future (Rock 2012). There is mounting evidence that body composition and metabolic 
markers serve as independent predictors of survival and cancer-specific survival in patients with 
various types (Rock 2012, Van Eckert 2015), meaning that optimizing lifestyle factors may have 
a direct influence on survival rates for patients of various cancer types. This may prove difficult 
for patients to do- many of the recommendations made by the guidelines are ambiguous, and 
effectively following the guidelines may be difficult for cancer survivors. Improving the clarity of 
the guidelines for cancer patients of all types will allow patients to better adhere to them and 
possibly improve their own survival time. 
PCa patients uniquely stand to benefit from adherence to physical activity guidelines both in 
combatting disease progression and side effects of therapy (Rock 2012). The guidelines indicate 
that there are benefits to maintaining or achieving a healthy weight after diagnosis, both in terms 
of disease progression and in reducing rates of adverse events (such as bone fractures and 
cardiovascular events). Finding ways for patients to maintain a healthy weight can be difficult 
because of the changes in body composition related to ADT, particularly if the patient has not 
maintained this body composition in the past. Despite these difficulties, it is important to find 
interventions that can allow for the maintenance of a healthy body composition. Exercise 
interventions have been studied as a way to promote compliance with physical activity guidelines 
and achieve healthier body compositions that favor less aggressive PCa progression and 
improvements in physical and muscular function (Galvao 2017, Winters-Stone 2015) Many of 
these interventions have proven to be effective. Because failure to comply with exercise guidelines 
in men with PCa undergoing ADT inevitably results in an increased difficulty adhering to the same 
guidelines and consequences that worsen disease prognosis (such as weight gain and obesity), it is 
important for patients to maintain appropriate levels of physical activity and a healthy weight early 
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and throughout treatment (Rock 2012). Exercise prescriptions that are effective and available to 
patients undoubtedly can help maximize the patient’s treatment. 
Exercise in PCa 
 Because PCa and ADT further exacerbate decrements in physical function and body 
composition, resistance training has been seen as a promising therapeutic modality to alleviate 
these adverse effects. A recent systematic review has found that combined aerobic and resistance 
exercise leads to improvements in QoL in the short and long term for cancer survivors (Morvwen 
2017), and another provided evidence that exercise can help treat cancer-related fatigue 
(Tomlinson 2014). It has also been documented that resistance training can prevent and treat 
detrimental effects of sarcopenia seen in these patients and improve physical function in PCa 
patients undergoing ADT (Galvao 2010, Hanson 2013, Winters-Stone 2015). The purpose of many 
exercise interventions in PCa have been to maximize gains in muscle function and functional 
capacity. Resistance training in particular has proven to show improvements in strength, 
endurance, and physical function in patients with localized PCa (Hanson 2013, Galvao 2017, 
Gaskin 2016, Winters-Stone 2015). There is also evidence that resistance training can lead to 
increases in lean mass (Hanson 2013, Galvao 2010), decreases in fat mass in (Winters-Stone 2015), 
or both (Wall 2017) in PCa patients despite ADT. Given the limited functional and exercise 
capacities of many PCa patients at the start of these exercise interventions and the known effects 
of PCa and ADT, many of the improvements found in physical function are quite high. Most 
studies examining resistance training in men with PCa find attenuated gains (but gains nonetheless) 
in strength and physical function similar to what would be described in healthy men of similar age, 
while there are less robust changes in body composition. Others, such as Winters-Stone et al (2015) 
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observed that resistance training can have significant positive effects on body composition and 
insulin sensitivity, both of which have been shown to have positive effects on overall survival.  
 Aside from improvements in objectively measured strength, endurance, body 
composition, and physical function, improvement in patient reported outcomes such as QoL has 
also been the target of exercise interventions. There is evidence that physical function and body 
composition both correlate with health-related QoL in cancer patients (Van Eckert 2015), both of 
which are dramatically affected by PCa and ADT (Dacal 2006). Exercise interventions have shown 
success in improving patient QoL, sometimes to a greater extent than objectively measured 
strength, endurance, and body composition (Galvao 2017). This may indicate that some 
interventions may have had a greater impact on overall patient QoL than can be attributed to gains 
in functional status. Interestingly, few studies list QoL as a primary outcome, though 
questionnaires are frequently used to measure the change in QoL over the course of the 
intervention. In the meta-analysis by Keilani et al. (2017) examining the effects of resistance 
training in PCa patients, while notable improvements in strength and body composition were 
found, there was insufficient data to determine the effect on QoL, partly due to varying assessment 
methods., Because resistance training may be used as an adjuvant therapy for the remainder of the 
patient’s life in order to ameliorate the effects of ADT, more work should be done to clarify what 
factors resistance training may affect besides strength and physical function in order to maximize 
the benefit to the patient. 
 Exercise is particularly important for patients undergoing ADT. There is evidence 
that resistance exercise can improve strength, endurance, and lean mass in men despite ADT and 
aging. There is much more evidence of this for men with PCa that has not yet become castration-
resistant. Exercise has been relatively contraindicated in PCa patients with bone metastases due to 
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concerns about skeletal injuries, possibly keeping patients who may be experiencing the greatest 
functional declines from a therapy that would alleviate these declines (Cormie 2013, Galvao 2011), 
though efforts to expand the benefits of exercise into CRPC and mCRPC patients have been on 
the rise. Cormie and colleagues (2013) made an important step in furthering the use of exercise as 
an adjunct therapy for PCa patients with bone metastases by providing evidence that exercise is 
“safe and well tolerated” in this population. Galvao et al (2017) recently also found no differences 
in rates of exercise-related adverse events, bone fractures, or bone pain between patients with bone 
metastases who complete multimodal aerobic and resistance training over a three-month period. 
These findings have opened the door for more research to be done involving exercise in mCRPC 
patients. Recent work has shown similar improvements in functional capacity for men with 
mCRPC as those with earlier-stage PCa, though there is still limited evidence with this population. 
 A recent meta-analysis examining resistance training in PCa found that resistance 
training is effective at improving body composition, 400-m walk time, and body composition 
(Keilani 2017). There is convincing evidence that resistance training can play a crucial role in the 
therapeutic treatment of PCa survivors. Despite this, there are still challenges that must be faced 
in order to make a clinically used therapy (Hanson 2016). Thus, the next challenge for exercise 
oncologists investigating PCa is to find ways that resistance training can be implemented as an 
adjuvant therapy to PCa patients of various disease stages, geographic areas, and socioeconomic 
statuses. Many of the barriers to exercise reported by men with PCa and people with other types 
of cancer include limited access to facilities, lack of motivation, feelings of embarrassment, and a 
lack of time (Ottenbacher 2011). The ideal exercise intervention for these patients would be safe 
to complete, accessible to patients who live in various areas, and be effective at improving strength, 
physical function, and body composition. Reaching each of these goals can be challenging. For 
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example, studies utilizing exercise interventions in CRPC patients have used machines which limit 
speed and force development, and have had trained staff supervising the patient for the duration of 
each exercise session (Cormie 2013, Galvao 2017). While this may be ideal for maximizing the 
safety of the exercise program, it may not be possible for every CRPC patient to have access to a 
trained staff, or to travel to a facility with the appropriate equipment for each exercise session. 
Commercial gyms may allow for some alleviation of this problem, but some geographic areas may 
have limited access to commercial facilities. Patients may also be unwilling or uncomfortable 
exercising in public, which could limit the number of patients who will complete an exercise 
intervention. It would undoubtedly be difficult to supply each CRPC patient with comparable 
resources to those that have been provided in exercise intervention studies in the past (van Waart 
2017). 
 One option that has received less exploration by researchers in PCa (and CRPC in 
particular) is home-based exercise. A home-based resistance training intervention can potentially 
provide a solution to many of the barriers to exercise that have been listed for men with CRPC- 
for example, a home-based exercise program may require less travel, can be completed away from 
other people, and may give patients more freedom to choose when they exercise. While home-
based exercise has not been deeply explored in men with mCRPC, there is evidence that home-
based exercise programs are feasible and safe for patients in the earlier stages of PCa (Kim 2017) 
and people with other types of cancer (Battaglini 2016, Spector 2014). Home-based interventions 
have shown some promise in improving cardiopulmonary and physical function, though levels of 
adherence to home-based exercise interventions may differ considerably based on the intervention 
and patient characteristics. For example, Battaglini et al (2016) found that patients pre-
hematopoietic cell transplantation patients assigned a moderate-to-high intensity aerobic training 
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program had relatively poor adherence to the program, with 30% (n= 6, N= 20) of autologous 
transplant patients and 35% (n=7, N=20) of allogenic patients completing more than 75% of 
possible exercise sessions, and the median number of sessions completed for both groups were 
under 50%. The authors attributed the adherence rates partially due to the high-intensity of the 
intervention and difficulties with accurate tracking of adherence to the intervention. Despite the 
relatively low adherence, the authors still found significant improvements in 6-minute walk 
distance and VO2, peak in the allogenic transplant group, indicating that the intervention was 
effective even with less-than-ideal participation. Spector (2014) et al also found that a combined 
resistance and aerobic exercise program improved cardiopulmonary capacity (mean improvement 
of 2 mL/kg/min) and objective measures of physical activity in breast cancer patients (Spector 
2014). Adherence to the home-based portion of exercise interventions also may differ from 
adherence in the facility-based portion in exercise programs that incorporate session both at home 
and a research facility. The exercise group in the study conducted by Winters-Stone et al (2015) 
used a combined program involving some home-based exercise sessions and some laboratory-
based exercise sessions- adherence to the laboratory sessions was 83% while adherence to home 
exercise sessions were 49%. Reasons for the differences in adherence are unclear and warrants 
further explanation. Despite some differences in adherence, there is evidence that home-based 
exercise can provide clinically meaningful benefits to cancer patients, and home-based exercise 
may offer solution to many of the barriers to exercise that face men with mCRPC. More research 
can potentially help overcome some of the current limitations of home-based exercise and expand 
the benefits of training to more PCa patients. 
One of the major complications in assessing the effectiveness of home-based exercise has 
been accurately measuring adherence to the exercise program.  Some studies have used 
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accelerometers to track data, but these have had a limited ability to store information, limiting how 
much information can be captured across the intervention (Spector 2014, Loprizini 2014). Other 
studies have utilized patient-reported exercise levels recorded on exercise logs (Johansson 2014). 
Exercise logs do not have the same level of accuracy as other adherence-measuring techniques 
when examining individual adherence rates (Dishman 1994, Wilbur 2005, Frost 2017). Activity 
trackers have provided a promising new way to quantify levels of physical activity away from a 
research facility. Several of these trackers have been shown to produce valid and useful data (Le 
2017, Evenson 2015, Parastoo 2017, Stahl 2016, Wahl 2017) and also allow for information to be 
recorded and accessible to researchers each time the device is synced to the cloud (Phillips 2018). 
Recent studies have provided evidence that many of these trackers can provide reliable information 
when used correctly, particularly tracking heart rate and steps (Parastoo 2017, Wahl 2017). The 
ability to objectively measure activity levels away from the research facility has allowed for better-
quality data to be obtained when examining home-based physical activity programs. These trackers 
have opened the door for more accurate home-based activity measures and may provide 
improvements in the validity of home-based exercise data. 
With recent findings that men with mCRPC can safely participate in exercise, the potential 
for home-based exercise to expand the number of patients that can benefit from resistance training, 
and improvements in technology to track adherence to home-based exercise programs, there is 
now an opportunity to see if home-based exercise can be a feasible and effective solution for 
combatting deleterious effects of mCRPC and ADT. This study hopes to address this and provide 
a useful first-step into determining if home-based exercise can improve the health and QoL of men 
with mCRPC. 
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CHAPTER 3: METHODS 
 
Participants 
 
Eligible participants for this study had been diagnosed with metastatic castration-resistant 
prostate cancer (mCRPC), were receiving ADT, had a total testosterone less than 50 ng/dL within 
4 weeks of enrollment, and were deemed capable of participating in moderate-to-vigorous physical 
activity by their referring physician. Participants were excluded if they were engaged in regular 
exercise totaling greater than 90 minutes per week or greater than three 30-minute sessions weekly 
(including strength training, aerobic training, or walking for six months prior to being contacted), 
undergoing chemotherapy, or had an uncontrolled cardiovascular or respiratory disease. Potential 
participants were referred to the research team by their medical oncologist. Referred patients were 
screened by the research team via telephone to determine their initial eligibility.  Patients that met 
the initial screening criteria and were interested in the study then completed a more thorough 
medical history to confirm eligibility. Prostate-specific antigen (PSA) levels, testosterone levels, 
date of diagnosis, and treatment history were extracted from the medical records during this 
process. Participants provided written informed consent upon explanation of study procedures at 
baseline testing, and the intervention began immediately following baseline testing.  
Design and Procedures 
Testing procedures were completed at the beginning of the 12-week exercise intervention and 
immediately upon its completion. Throughout the intervention, participants were contacted weekly 
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to provide support and encourage compliance throughout the intervention. Deviations from the 
exercise protocol were recorded to identify the most prominent barriers to exercise.  
 
Figure 1. Study Design. 
 
Patient Reported Outcomes 
 
Patient reported outcome questionnaires were given to patients prior to each testing session. 
Participants completed these questionnaires at home and to brought them to the respective testing 
sessions or completed immediately upon arrival to the testing session if they failed to fill the 
questionnaire out beforehand. Fatigue was measured using the FACIT-Fatigue, a 13-question 
survey measuring patient fatigue. All responses are scored from 0-4 and a high scale score 
represents a higher response level. Depression was measured using the Hospital Anxiety and 
Depression Scale, a concise, one-page self-administered form that categorizes anxiety and 
depression.  The total score goes from 0-21, and scores are categorized from minimal to severe 
depression/anxiety. Quality of Life (QoL) was measured using the Functional Assessment of 
Cancer Therapy-Prostate. The FACT-P is composed of both multi-item scales and single-item 
measures. These include physical, social, emotional, and functional well-being, along with an 
assessment of prostate-specific health status, five functional scales, three symptom scales, a global 
health status / QoL scale, and six single items. All of the scales score from 0-4 and a high scale 
score represents a higher response level.  
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Body Composition 
 
Lean mass, fat mass, and bone mineral content were assessed using a whole-body dual-
energy x-ray absorptiometry (DXA) scan (Discovery, Hologic, Marlborough, MA, USA). All 
scans were measured by the same trained densiometrist. 
Physical Function 
 
 Physical function was assessed with simulated activities of daily living, as described 
previously (Hanson 2013, 2017). Tests included the 6m rapid walk test, 2.44m timed up and go 
test, timed chair stands, a stair climb task and 400m walk test. Participants completed a practice 
trial of each test (except for the 400m walk) before a measured trial to familiarize them with each 
task. Participants were given two measured attempts to complete each test, except for the 400 m 
walk, which will only be completed once. Participants were given 30 seconds of rest between 
attempts. In addition, the short physical performance battery (SPPB), which is comprised of 5 chair 
stands, 2.44m usual walk, and 10 second balance tests), was performed as described by Guarlnik 
1994. Participants were given two attempts to complete each test in the battery and a composite 
score from 0-12 was determined, with higher scores indicating higher function.  
Muscle Function 
 
 Muscle function was measured with multiple tests, including rate of force development, 
peak torque, maximal strength, and muscular endurance. Peak torque and rate of force 
development of the dominant leg knee extensors was measured using isometric dynamometry 
(HUMAC NORM, CSMI, Stoughton, MA, USA). Participants completed three familiarization 
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trials, in which they were asked to extend their knee at 50%, 75%, and then 90% of their perceived 
maximal effort against the dynamometer. Participants were given one minute of rest between each 
trial for the familiarization trials and the maximal-effort trials. Participants attempted to extend 
their knee as quickly and forcefully as possible for five seconds. At least three maximal effort trials 
were performed for each participant. If the highest value was obtained on the third maximal trial, 
additional repetitions were performed until a lower value is obtained.  
Maximal isotonic strength was recorded as the heaviest weight that could be lifted one time 
through a full range of motion and was be recorded for both chest press and leg press as used 
previously (Hanson 2013). Participants completed two practice trials in which they used a minimal 
weight and performed five repetitions. Participants then lifted progressively heavier weights for a 
single repetition until failure, resting one minute between attempts. The highest amount they are 
able to lift was recorded as their maximal strength. After two minutes of seated rest, participants 
completed a repetition test using a resistance set to 70% of their maximal strength for as many 
consecutive repetitions as possible without stopping (a pause of longer than one second between 
repetitions was deemed the end of the test). This will be recorded as their muscular endurance.  
Cardiorespiratory Fitness 
 
Cardiorespiratory fitness and peak oxygen uptake were measured by a maximal-effort 
graded exercise test performed by walking on a treadmill (GE Case ECG and T2100 GE treadmill 
system, GE Healthcare, Little Chalfont, United Kingdom). Respiratory gases were collected 
throughout the test and analyzed using a metabolic cart (TrueOne® 2400, Parvo Medics, Sandy, 
UT, USA) to determine oxygen utilization and carbon dioxide production. The metabolic cart was 
be turned on thirty minutes prior to the test and calibrated immediately before the test. Resting 
VO2 was recorded for three minutes immediately prior to the start of the testing protocol by letting 
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the patient sit stationary in a chair as respiratory gases were collected. The test was composed of 
two-minute stages in which participants begin by walking slowly on the treadmill, and either 
speed, grade, or both were increased in the subsequent stage. The participant’s heart rate was 
measured continuously throughout the test and recorded on a testing form each minute. The 
participant’s rate of perceived exertion (RPE) was measured in each stage thirty-seconds prior to 
the initiation of the subsequent stage. Participants continued the test to fatigue.VO2 peak was 
recorded as the highest 15-second average of VO2 values and were used as a marker of aerobic 
fitness. 
Exercise Intervention 
 
The 12-week home-based intervention consisted of both walking (aerobic component) and 
resistance exercise using elastic bands (Hygenic Corporation, Akron, Ohio, US), as used 
previously in breast cancer patients (Spector 2014). Participants were given four bands of differing 
color (yellow, red, green, and blue) and levels of elastic tension. The intervention is aimed at 
progressively increasing training volume to comply with physical activity guidelines set by the 
American College of Sports Medicine for older adults (Garber 2011) and cancer patients (Schmitz 
2010). A member of the research team demonstrated all exercises to the participants after the 
graded exercise test. Participants were also given a booklet which included a list of each exercise 
as well as pictures that demonstrate how each exercise is performed. Upper body strength exercises 
included lateral and front raises, wall or modified floor push-ups, chest press, bent row, arm curls, 
and triceps extensions. Lower body strength exercises included chair squats, chair leg raises, 
hamstring curls, and calf raises. Four core strengthening exercises were also included in the 
program, and include the bridge, crunch, reverse crunch, and side crunch. Participants were also 
instructed to perform stretching exercises of major muscle groups after the walking component of 
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their exercise program. Participants were asked to record all intervention activities in an exercise 
log, which was provided in the booklet along with the illustrations of resistance exercises and 
stretches. Participants were also given a wrist based physical activity tracker (Garmin vivosmart 
HR, Garmin, Olathe, Kansas, US) to wear throughout the trial. The tracker is capable of recording 
heart rate, activity minutes, activity duration, steps, and distance traveled, and a member of the 
research team synced the watch to an online account so that this information could be extracted 
during the 12-week trial. Participants were shown how to sync the physical activity tracker to the 
online account with a computer or smart phone so that information obtained from the tracker was 
visible to the research team. Participants were asked to sync the information regularly (at least 
once per week). 
To stimulate a training effect following recommendations from the American College of 
Sports Medicine, from week 1 to completion of the study, the walking exercises were progressively 
increased from 15 to 30 minutes and intensity from 40% to 65% of heart rate reserve (see Table 
1). Elastic bands were used for the resistance training. Participants were instructed to perform 12 
to 15 repetitions per exercise beginning with the light- or medium-strength band and progress to 
the heaviest strength band as ability permitted. Once a participant was able to comfortably 
complete 15 repetitions for all prescribed sets, they were instructed to increase resistance by 
moving up to the next band. 
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Statistical Analysis 
 All statistical analysis was completed using SPSS version 24 (SPSS, INC., Durham, 
NC, USA). The α level was set a priori to α=0.05 for tests for significant differences. Descriptive 
statistics were reported as mean ± standard deviation. The research team established a priori that 
home-based exercise would be deemed feasible in this population if greater than 67% of men who 
completed baseline testing also completed post-testing and completed at least 75% of the 
prescribed exercises. Differences between the number of walking sessions observed by the Garmin 
vivosmart HR device and the number of sessions reported in exercise logs by participants were 
measured using two-sample t-tests; these were performed to compare differences in each week of 
the intervention as well as the total number of walking sessions throughout the intervention. 
Differences between the adherence rate of specific exercises in the program and the mean 
Table 1. Summary of Home-Based Exercise Intervention 
       
 Walking  Resistance Training 
       
Week 
Sessions per 
Week 
Duration 
(min) 
Intensity 
(%HRR)   
Sessions per 
Week 
Sets per 
Session 
1 2 15 40-50  1 1 
2 2 15 40-50  2 1 
3 3 20 50-60  2 2 
4 4 30 50-60  3 2 
5 4 22 50-60  3 2 
6 4 22 50-60  3 2 
7 4 25 55-65  3 2 
8 4 25 55-65  3 2 
9 4 25 55-65  3 2 
10 4 30 55-65  3 3 
11 4 30 55-65  3 3 
12 4 30 55-65  3 3 
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adherence to the resistance training prescription were compared using a one-sample t-test. Changes 
in QoL and physiological parameters were measured using paired-samples t-tests. 
 
Table 2. 
 
Feasibility Estimations 
 
% n/N Estimate (95% CI) 
50% (15/30) 50.0% (31.3%, 68.7%) 
60% (18/30) 60.0% (40.6%, 77.3%) 
67% (20/30) 66.7% (47.2%, 82.7%) 
70% (21/30) 70.0% (50.6%, 85.3%) 
80% (24/30) 80.0% (61.4 %,92.3%) 
83% (25/30) 83.3% (65.3%, 94.4%) 
90% (27/30) 90.0% (73.5%,97.9%) 
100% (30/30) 100.0% (88.4%,100.0%) 
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CHAPTER 4: RESULTS 
Patient Recruitment 
 Thirty-two men with mCRPC undergoing ADT were referred to the study. As this 
study is on-going, the analysis will focus on only those patients who have or would have completed 
post-testing up to now. While 13 men have completed baseline testing, 3 are currently participating 
in the study. Because the 3 participants currently enrolled have not had the opportunity to complete 
post-testing or be deemed ineligible due to lack of exercise adherence, they have been excluded 
from this analysis, leaving 10 men available for analysis. Of these 10 men, 7 completed post-
testing, netting a 70% completion rate. Adherence to the exercise protocol and changes in 
physiological and QoL parameters were analyzed on the 7 men who completed post-testing.  
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Figure 2. Consort Diagram.  
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Exercise Adherence 
 The mean number of sessions completed was 34.9 (80.7% of prescribed) for walking 
(Table 4) and 27.3 (85.3% of prescribed) for resistance training (Table 5) according to the exercise logs. 
The mean number of cumulative exercise sessions completed for both aerobic (walking) training and RT 
were plotted against the number of cumulative exercise sessions prescribed for the respective type of 
training (Figure 2 and 3). For both types of exercise, they did not appear to be a point in time during the 
intervention at which adherence to prescribed exercise decreased significantly. The mean number of days 
in which Garmin vivosmart HR data was extracted was 68.7 ± 9.2 (81.8 ± 11.0%) days for each participant. 
  
Table 3. Baseline Patient Characteristics (N=10) 
Age 71 ± 10.1 
Height (cm) 172.4 ± 7.1 
Body Mass (kg) 88.1 ± 20.1 
Body Mass Index (kg/m2) 29.64 ± 3.4 
Time from PCa diagnosis (years) 8.4 ± 2.4 
Time from mCRPC diagnosis (months) 8.2 ± 5.0 
Length of ADT (months) 10.6 ± 7.0 
ADT type [n, (%)]  
Luprolide 7 (100%) 
Enzaludamide 2 (20.0%) 
Abiraterone 5 (50.0%) 
Other Prior Treatments [n, (%)]  
Chemotherapy 5 (50.0%) 
Radiation Therapy 7 (100%) 
Prostatectomy 7 (100%) 
PSA (ng/mL) 12.4± 4.5 
Total T (ng/mL) 6.8 ± 2.1 
Mean ± SD 
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Table 4. Walking Adherence by Exercise Log and vivosmart HR (n=7) 
     
Week 
Sessions 
Prescribed  
per week 
Mean Sessions  
Completed (exercise log) 
Mean Sessions  
Observed (vivosmart HR) 
P 
Value 
1 2 1.9 ± 0.4 (92.9%) 0.9 ± 0.7 (42.9%) 0.006 
2 2 2.0 ± 0.0 (100%) 2.0 ± 1.2 (100%) 1.000 
3 3 2.7 ± 0.5 (90.5%) 1.4 ± 1.4 (47.6%) 0.040 
4 4 2.7 ± 1.5 (67.9%) 2.0 ± 1.6 (50%) 0.410 
5 4 3.0 ± 1.2 (75.0%) 2.9 ± 1.2 (71.4%) 1.000 
6 4 3.0 ± 1.4 (75.0%) 3.0 ± 1.6 (75.0%) 0.870 
7 4 3.0 ± 1.6 (75.0%) 2.1 ± 1.9 (53.6%) 0.378 
8 4 3.3 ± 1.1 (82.1%) 2.1 ± 1.6 (53.6%) 0.143 
9 4 3.3 ± 1.0 (82.1%) 2.6 ± 2.0 (64.3%) 0.401 
10 4 3.4 ± 1.0 (85.7%) 3.6  ± 1.1 (82.3%) 0.805 
11 4 3.3 ± 1.5 (82.1%) 3.0 ± 1.8 (75.0%) 0.754 
12 4 3.1 ± 1.5 (78.6%) 1.4 ± 1.4 (35.7%) 0.045 
Total: 43 34.7 ± 6.1 (80.7%) 27.0 ± 12.2 (62.8%) 0.161 
Mean ± SD (% of prescribed) 
     
 
 
 
Figure 3. Mean number of cumulative walking sessions completed by participants during the 
course of the 12-week intervention as reported on the participant’s exercise log plotted against the 
cumulative number of walking sessions prescribed. Data is reported as mean ± standard deviation. 
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Table 5. Resistance Training Adherence (n=7)  
    
Week 
Prescribed 
Sessions 
Completed  
Sessions 
1 1 1.0 ± 0.0 (100.0%) 
2 2 1.9 ± 0.4 (92.9%) 
3 2 2.0 ± 0.0 (100.0%) 
4 3 2.4 ± 0.8 (81.0%) 
5 3 2.1 ± 0.7 (71.4%) 
6 3 2.3 ± 1.0 (76.2%) 
7 3 2.3 ± 0.5 (76.%) 
8 3 2.7 ± 0.5 (90.%) 
9 3 2.9 ± 0.4 (95.2%) 
10 3 2.1 ± 0.7 (71.4%) 
11 3 2.9 ± 0.4 (95.2%) 
12 3 2.79 ± 0.5 (90.5%) 
Total 32 27.3 ± 4.0 (85.3%) 
Mean ± SD    
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Figure 4. Mean number of cumulative RT sessions completed by participants during the course of 
the 12-week intervention as reported on the participant’s exercise log plotted against the 
cumulative number of R sessions prescribed. Data is reported as mean ± standard deviation.  
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Table 6. Adherence to Specific Exercises (n=7)   
 Mean Percent of   
Exercise Sessions Completed   P-value 
Lateral Raise 85.3% ± 11.7%  0.50 
Front Raise 85.3% ± 11.7%  0.50 
Pushup (wall, bench, floor) 85.3% ± 11.7%  0.50 
Chest Press 85.3% ± 11.7%  0.50 
Bent Row 84.2% ± 11.7%  0.49 
Bicep Curl 85.3% ± 11.7%  0.50 
Tricep Extension 85.3% ± 11.7%  0.50 
Chair Stand 85.3% ± 11.7%  0.50 
Knee Ext 85.3% ± 11.7%  0.50 
Hamstring Curl 85.3% ± 11.7%  0.50 
Calf Raise 75.0% ± 27.9%  0.19 
Bridge 56.0% ± 37.6%  0.05 
Crunch 58.0% ± 35.8%  0.06 
Side Crunch 58.0% ± 35.8%  0.06 
Reverse Crunch  56.0% ± 37.6%  0.05 
Mean ± SD. Comparison of completion rate of individual exercises to mean session completion 
rate (85.3%) 
 
For most exercises, there was no difference for adherence. There was a significant 
difference between adherence to the bridge and reverse crunch exercises, and there was and there 
was a trend toward differences in adherence for the crunch and side crunch. 
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Table 7. Changes in QoL and Fitness Parameters (n=7)   
  Parameter Baseline 
Post-
Intervention P-value 
      
  FACIT 42.3 ± 4.7 41.75 ± 6.9 0.458 
  HADS 8.3 ± 4.3 5.2 ± 1.5 0.098 
  FACT-P Total 119.3 ± 14.5 122.2 ± 15.8 0.407 
  Physical 22.3 ± 2.3 21.3 ± 3.8 0.298 
  Social/Family 23. 3 ± 4.5 24.2 ± 5.0 0.234 
  Emotional 17.0 ± 2.9 18.0 ± 4.2 0.259 
  Functional 18.8 ± 6.3 20.8 ± 4.0 0.175 
  Prostate-Specific 34.3 ± 4.0 33.3 ± 4.9 0.371 
  Lean Mass (kg) 59.3 ± 7.5 59.2 ± 6.4 0.461 
  Fat Mass (kg) 29.3 ± 6.7 28.7 ± 6.4 0.145 
  Bone Mineral Density (g/cm2) 1.2 ± 0.2 1.2 ± 0.2 0.21 
  Short Performance Physical Battery 10.6 ± 2.2 10.6 ± 2.2 0.50 
  Knee Extension Peak Torque (N*m) 142.8 ± 58.9 150.9 ± 55.7 0.198 
  Chest Press 1 RM (kg) 59.6 ± 18.1 57.7 ± 19.1 0.112 
  Chest Press reps at 70% 1 RM 14.4 ± 6.3 16.0 ± 8.6 0.276 
  Leg Press 1 RM (kg) 139.6 ± 59.5 154.5 ± 63.5 0.023 
  Leg Press reps at 70% 1RM 12.9 ± 8.6 11.4 ± 7.1 0.193 
  8' Timed Up-and-Go (s) 7.1 ± 1.7 7.3 ± 1.5 0.356 
  6 m rapid walk (s) 4.8 ± 1.5 4.8 ± 1.0 0.391 
  Stair Climb (s) 6.9 ± 3.3 7.0 ± 3.7 0.412 
  400 m walk (s) 
350.4 ± 
127.2 343.2 ± 107.4 0.349 
  Relative VO2 peak (ml/kg/min) 20.3 ± 3.9 22.3 ± 5.0 0.013 
  Absolute VO2 peak (L/min) 1.8 ± 0.3 2.0 ± 0.4 0.013 
  Mean ± SD    
 
 
Patient Reported Outcomes 
 There were no significant improvements in patient reported QoL measures. 
Participants reported the biggest improvement in depression as measured by the HADS scale, with 
a percent change of -37.3%. This was the only patient reported outcome to approach significance. 
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Body Composition 
 There were no significant changes in body composition after the exercise 
intervention. The greatest change was observed in fat mass (-2.0%). 
Physical Function 
 There was no significant change in SPPB score, with some participants marginally 
improving or declining. One participant improved their score by two points, but none of the other 
participants experienced a change of greater than one point.  
There were no significant changes in other physical function tests performed. The greatest 
percent change was in the 400 m walk (-2.1%). The mean time to complete the TUG and stair 
climb increased after the intervention, while the 400 m walk and 6 m rapid walk times decreased 
(improved). There was a great deal of variance in performance change for each of the tests 
performed.  
Muscle Function 
 There was no significant change in maximal torque produced in the isometric knee 
extension. Maximal strength on the leg press improved significantly by 10.7% after the 
intervention (p=0.023) and was the only muscular strength or muscular endurance parameter to 
change. Maximal leg strength improved and muscular endurance tested at 70% of maximal 
strength declined, maximal upper body strength on the chest press declined, and upper body 
endurance tested at 70% of maximal strength improved slightly. Only the change in maximal leg 
strength reached statistical significance. 
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Cardiorespiratory Fitness 
Significant differences were found between VO2 peak results (both relative and absolute) 
at baseline and post-testing (p=0.013), with an improvement of 9.7%. This was a comparable 
percent increase to the observed increase in maximal strength on the leg press, the only other 
parameter to significantly change as a result of the intervention. All of the participants experienced 
an improvement in cardiorespiratory fitness as a result of the intervention. 
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CHAPTER 5: DISCUSSION 
 
 This study is the first to examine a 12-week home-based exercise intervention in 
mCRPC undergoing ADT. This intervention had enrollment rates similar to other studies in this 
population, and 70% of participants who enrolled also completed the intervention while also 
adhering to greater than 80% of all prescribed aerobic and resistance training sessions. This 
exceeded the adherence goal for this preliminary study and supported our hypothesis that home-
based exercise is feasible for men with mCRPC undergoing ADT. Additionally, cardiorespiratory 
capacity and maximal lower body leg strength significantly increased with training. These findings 
suggest that men with mCRPC are capable and willing to complete exercise at home, potentially 
opening up a new avenue to improve patient health and QoL in areas in which supervised exercise 
may not be feasible. 
 While the effects of exercise in PCa patients with bone metastases have not been 
studied extensively due to safety concerns (Cormie 2013, Galvao 2011), this home-based study in 
men with mCRPC suggests that both aerobic and resistance exercise performed at low to moderate 
intensity can be safely completed. One incident occurred during in this study in which one 
participant experienced an exacerbation of a preexisting condition unrelated to PCA resulting in 
sharp knee pain immediately following baseline testing and the participant declined further 
participation in the study.The rates of completion in this study are comparable to the 79% reported 
in another study using the same home-based exercise intervention in BCa patients (Spector 2014). 
Moderate intensity exercise and frequent supportive conversations with participants have been 
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shown to be related to high levels of adherence in home-based exercise (Jansons 2017). The 
resistance training for the current study was 12-15 repetitions per exercise and walking was 
prescribed from 40-65% of heart rate reserve, both of which are moderate exercise intensities, and 
may have contributed to the high adherence rates we observed. Moreover, information obtained 
from the vivosmart HR activity tracker also allowed for the research team to have informed 
conversations about the patient’s level of physical activity during the weekly phone conversations 
and to intervene if participant motivation appeared to decrease. Little is known on the ability of 
wearable activity trackers to improve adherence to home-based exercise in clinical populations 
(Hartman 2018, Phillips 2017), let alone in terminal cancer patients, and these interventions have 
not explored whether or not there is a synergistic effect of the activity tracker and weekly contact 
with participants. It has been suggested that there may be an additive benefit of a wearable activity 
tracker and behavioral interventions such as counseling (Nguyen 2017, Naumann 2011, but little 
work has been done in this field to date, and the results thus far have found varying levels of 
success in these types of interventions (Zhang 2017) (Phillips 2017) The level of adherence to the 
exercise intervention in this study may warrant additional research into this combined strategy of 
activity tracking alongside weekly contacts with patients. 
 The reported levels of adherence to this home-based intervention are comparable 
to laboratory-based exercise interventions for PCa patients with bone metastases, as Cormie (2013) 
and Galvao (2017) reported adherence rates of 83% and 89% respectively. Home-based exercise 
interventions may experience a lower percentage of completion than those completed in laboratory 
settings (Cox 2003), though there is also evidence that weekly phone conversations can improve 
home-based exercise adherence and mitigate these differences (Jansons 2017). 
  -  
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 Participants self-reported high rates of adherence in the exercise logs (83%) of all 
sessions, which supported our hypothesis of at least 75% of all sessions completed. There was no 
significant difference in the total number of walking sessions observed between the Garmin 
vivosmart HR device and the number of exercise sessions reported by the participants in the 
exercise logs overall (p=0.161), but there were significant differences in the number of sessions 
observed for week 1 (p=0.006), week 3 (p=0.040), and week 12 (p=0.045) (Table 4). Thus, this 
study provides evidence that activity trackers such as the vivosmart HR may provide an effective 
way to objectively measure exercise adherence in this population. However, data was only able to 
be captured on 71.8% of the days of the intervention, with a mean of 15.3±9.2 days missed (Figure 
2). Despite weekly contact with the participants, they did occasionally forget to sync or wear the 
watch for periods throughout the intervention. Aside from having incomplete data, methods used 
to define a walking session from heart rate and step data has not been validated in this population. 
It was also not possible to observe resistance training sessions on the data obtained from the 
vivosmart HR device due to the reliance on changes in heart rate and step counts to determine 
when patients were exercising. Another important qualifier on these findings is that our method of 
determining a walking session has limited specificity: it could be possible for participants to 
perform physical activity unrelated to the exercise program that would appear as a walking session 
by the definition we used. Nonetheless, the percentage of data that we were able to extract in this 
feasibility study and the nonsignificant difference between the total number of observed sessions 
between the vivosmart HR and the exercise logs should encourage further exploration of the 
utilization of these trackers in this population, particularly focusing on improving the specificity 
and reliability of the activity tracker. 
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 While participants were able to complete a high percentage of exercise sessions, 
not all exercises were completed at the same rate in these sessions (Table 6). Participants reported 
the lowest adherence for abdominal and core exercises This finding emphasizes the importance of 
exercise selection in designing effective exercise programs for men with mCRPC, as prescribing 
exercises that these men can/will not perform will decrease self-efficacy and limit the benefit of 
the exercise program. The lower adherence to the core training may limit the increases in upper or 
lower body strength from transferring to improved physical function. PCa preferentially 
metastasizes to the pelvis and spine over other bones in the body, potentially contributing to the 
added difficulty in completing these exercises (Kahki 2013, Gandaglia 2014). Other studies 
analyzing resistance exercise in men with mCRPC have avoided excessively loading tissues with 
PCa metastases (Galvao 2017, Cormie 2013). While it is impossible to know without determining 
metastases locations in our participants, there may be a relationship with home-based exercise 
adherence and location of bone metastases in this population. The relationship between 
improvements in strength/physical function, site of bone metastases, and exercise adherence may 
warrant further explanation and be integral in optimizing exercise prescription in this population. 
 The lack of a plateau in the number of training session completed vs. prescribed 
indicates the training volume used in this intervention did not adversely affect adherence. This is 
an important finding, as previous work indicates that men with metastatic PCa  undergoing ADT 
can train at a higher intensity than what was utilized in this intervention (Galvao 2017). Because 
it was previously unknown if men with mCRPC undergoing ADT would adhere to a home-based 
exercise program, the current study utilized a conservative approach and prescribed a training 
volume that had successfully been completed by BCa survivors (Spector 2014). Collectively, our 
successful feasibility and adherence in this preliminary study and in conjunction with previous 
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work (Galvao 2017, Cormie 2013) leads us to hypothesize that metastatic prostate cancer patients 
may be physically able to partake in larger training volumes or greater training intensities, even in 
the home-based setting. This may allow for greater improvements in muscle strength, physical 
function, and ultimately QoL.  
 Cardiorespiratory fitness (p=0.013) and maximal leg strength (p=0.023) were the 
only physiological markers to significantly change after the exercise intervention. Previous work 
in men with metastatic PCa has found 11 and 8% improvements in maximal strength in the lower 
extremity as a result of resistance training (Cormie 2013, Galvao 2017), which is comparable to 
the 10.7% improvement in leg strength observed in this study.  Interestingly, the improvements 
observed in cardiorespiratory fitness were not observed in the 400 m walk test, despite the 400 m 
walk being known to correlate well with VO2 peak and has been used as a surrogate marker for 
cardiorespiratory fitness in this population (Keilani 2017) (Galvao 2006). The exact reason for this 
is unclear, but it may result from the lack of a familiarization session in this study or the difference 
in the variance of 400 m walk scores compared to VO2 scores. Studies have conflicting results on 
the ability of exercise to improve body composition during ADT (Galvao 2006, 2010; Hanson 
2013; Winter-Stone 2015) or objective measures of physical function in these patients (Galvao 
2017; Winters-Stone 2016) and the lack of significant changes in lean or fat mass support our 
hypothesis. It is worth noting that, while only VO2 and leg press 1 RM significantly improved, 
there were no tests in which participants performed significantly worse at post-testing than at 
baseline. Given the harsh nature of mCRPC and its treatment, this may still be seen as a potential 
positive outcome for these individuals. 
 This is the first study to report on the effect of an exercise intervention on maximal 
upper body strength and endurance in mCRPC patients, as Galvao and colleagues (2017) exercised 
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caution and limited the use of baseline and post-testing 1-RM chest press due to lesions in 
potentially dangerous areas. There were no adverse events related to upper-body 1-RM or 
endurance testing, suggesting that strength testing using a chest press machine appears safe in this 
population, though the generizability of this finding is limited by a small initial sample size. 
 Unlike maximal lower body strength, maximal upper body strength was unchanged 
after the intervention. Reasons for this are unclear, as generally speaking, resistance training has 
been highly effective in improving strength in PCa populations (Hanson 2016). We speculate that 
the increased use of lower extremity muscles from the walking sessions supported strength 
development, or that the lower extremity exercises (particularly the chair stands/squats) provided 
a more effective overload compared to the upper body exercises at improving strength. Given that 
the tests for muscular endurance at baseline were used with 70% of the 1-RM used at baseline, the 
decrease in endurance may be attributable to the difference in absolute weight lifted from baseline.  
 This study did not find significant improvements in patient reported QoL, though 
there was a trend toward lower depression scores (p=0.091). Depression has been reported to drive 
cancer progression (Cheng 2018), and ADT has been shown to worsen depressive symptoms in 
PCa patients (Gagliano-Juca 2018). The side effects of ADT, and “super-castration” in particular, 
have dramatic negative effects on patient QoL and physical function that are (Pezaro 2013, Tucci 
2018). Given that the men are terminally ill, particular consideration must be made to maximize 
both quantity and QoL in this population. In this study, we have shown that these men are willing 
and able to complete an exercise intervention with minimal barriers to entry (as it only requires 
elastic bands and walking space) aimed at combatting the negative effects of treatment. We have 
also provided evidence that men completing this intervention do not experience significant 
declines in body composition, QoL, or physical function despite their advanced disease and 
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treatment. This study, and future work in this field, will open the door to allow mCRPC patients 
to have increasingly more control over their own health and treatment symptoms, improving the 
patient’s ability to avoid sacrificing quality or quantity in their last months. 
 This study had several strengths. Weekly contact was made with each participant 
enrolled in this study, which has been shown to increase adherence to exercise programs (Jansons 
2017). These contacts both allowed the research team to intervene when adherence may have 
dropped and to answer any questions that patients had in a timely manner.  Participants in this 
study were contacted frequently by the same researcher, allowing for a strong rapport to be created. 
This study is ongoing and will be recruiting participants from three different centers (UNC Chapel 
Hill, Duke University, and Wake Forest University), enabling the research team to recruit broadly 
from the state of North Carolina. The exercise intervention used in this study generally allowed 
for strong rates of adherence, as exercise bands are portable and the aerobic portion of the program 
could be completed as long as participants were able to walk. This program gave control of the 
absolute level of resistance used and of the time in which exercise sessions were completed to the 
participants. This likely helped adherence rates, as self-efficacy has been deemed a strong predictor 
of exercise adherence in both PCa and BCa patients (Pinto 2009) (Craike 2016). 
 There were limitations in this study that could affect the interpretation of results. 
This is a single arm study and the lack of a control group limits the degree in which a causal 
relationship between observed physiological changes can be attributed to the exercise intervention. 
A control group would have been expected to show negative changes in muscle and fat mass given 
the nature of mCRPC and ADT, particularly super-castration (Pezaro 2013), but the degree in 
which this decrement occurs is unknown. It may be possible that maintenance of baseline physical 
function scores would be a strong improvement from a control group’s performance, or that some 
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of the observed changes do not differ significantly from what would be expected from this 
population. Another limitation was the lack of a familiarization session before the baseline testing 
session. However, practice trials were performed and patients verbally confirmed they were 
comfortable with each activity before testing. Because patients came to our facility from all across 
the state of North Carolina, testing was completed in a single session and residual fatigue from 
previous tests may have been a possible confounder. the decision to limit the amount of patient 
burden was made in order to maximize recruitment and the likelihood that participants would 
enroll.  
 In conclusion, this study provides preliminary evidence that men with mCRPC are 
able and willing to complete a home-based combined aerobic and resistance training program. 
There is limited information about the efficacy of exercise in this population, and the only work to 
date examining resistance training with this population has been highly supervised and tailored to 
the individual. The findings of this study indicate that patients without access to professional 
supervision may still benefit from aerobic and resistance training. Given their advanced disease 
and physical state, these men may stand to gain the most from a safe and effective exercise training 
program, but more work must be done to quantify how effective home-based exercise can be at 
improving patient health and QoL in this population. Future work in this area should aim to 
capitalize on the strategies used in this study to maximize adherence, including routine contacts 
with patients and tracking their physical activity in real time. 
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APPENDIX A 
 
LCCC 1613 Pilot Study: Feasibility of of a Home-Based Exercise Intervention Program 
for Patients with Metastatic Castration-Resistant Prostate Cancer  
  
Exercise Booklet  
  
  
Whole Body Stretch – stretching should be done after a 5 – 10 minute warm-up with 
aerobic exercise (for example, a brisk walk) or gentle movement.  Do not aggressively 
stretch cold muscles.  
1. Neck (Hold 10-15 sec each side)  
  
  
2. (Hold stretch 10-15sec)  
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3. Chest/ Shoulder (Hold stretch 10-15 
each side)  
  
  
  
  
  
  
  
  
4. Back (Hold stretch 10-15 sec)  
  
  
  
  
5. Scapula (Hold stretch 10-15 sec)  
  
  
  
6. Quads (Hold stretch 10-15 sec)  
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7. Hamstrings (Hold 10-15 sec each leg)  
  
  
  
8. Calves (Hold 10-15 sec each leg)  
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Upper Body Shoulders  
  
1a. Lateral Raises (1-3 sets / 10 - 15 
repetitions)* – start position  
  
  
  
1b. Lateral Raises – end at shoulder 
height  
  
  
  
          
        2a. Front Raises – start position  
  
  
  
  
      2b. Front Raises – end at shoulder 
height  
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Weight Training Exercises – Upper Body - Chest  
  
3a. Wall Pushup – starting position  
  
  
  
  
3b. Wall Pushup – lower yourself towards 
the wall keeping your body straight.  
  
  
          
        4. Bench Pushup  
  
  
  
  
      5. Floor – Modified Pushup  
  
  
  
For the chest exercise, choose the one most appropriate for you according to your fitness 
level. The wall pushup is beginner level, bench is intermediate and more advanced is the 
floor pushup.  
  -  
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6a. Chest Press – starting position  
  
 
  
6b. Chest Press - ending  
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Upper Body – Back  
  
7a. Bent Row – Keep your back straight and 
head in-line with spine.  
  
7b. Bent Row – Pull back keeping elbows in 
towards body and shoulder blades slide 
toward each other.  
  
  
Make sure you keep your back straight to ensure that you don’t hurt your back! 
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Upper Body Arms 
8a. Arm Curls (you can also use a dumbbell, or 
canned food).   
  
  
8b. Arm curls - You can do both arms or 
alternate each arm (1-3 sets / 12 
repetitions).  
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9a. Tricep – Front Arm Stretch – start position  
  
  
9b. Tricep – Front Arm Stretch – end 
position  
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Lower Body  
  
10a. Chair Squats – start standing or sitting.  1- 
3 sets / 15 repetitions.  
  
 
  
  
10b. Chair Squat – slow controlled sitting in 
and standing up from the chair.  
  
 
  
11. More advanced squat exercises if you have an 
exercise ball at home or ….  
  
12. …it can be done freestanding but be very 
careful of form. Do not let your knees go 
past your toes. Only go to 90 degrees 
maximum when squatting.  
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13a. Chair leg raises (start without band or use low 
resistance with band and increase resistance as you 
get stronger).  
 
13b. Chair leg raise – lift leg up but do not 
lock the knee or hyperextend.  
  
 
   
14a. Hamstring curls (can be done without a band 
depending on fitness level).  
  
 
14b. Hamstring curls with band.  
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15. Calf Raises.  Start standing then rise up on 
your toes squeezing the calf muscle for a few 
seconds then release and come back down.  
Repeat 1-3 sets / 15-20 repetitions.  
  
  
  
      
Weight Training Exercises – Core  
(Abdominals)  
  
For core exercises, perform 1 - 3 sets of each 
exercise. 12 - 20 repetitions per set for each 
exercise.  
1a. Bridge (works gluteus, abdominal and 
lower back muscles).  
  
 
1b. Bridge – squeeze your glutes and 
hamstrings and raise up and hold for a count of 
4 then lower back down to the floor.  Repeat.  
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2a. Crunches – start with knees bent as shown, 
arms crossed over chest or hands behind head.  
  
2b. Crunches- contract abs and lift shoulders off 
floor then lower back down.    
  
  
3a. Obliques – start with ankle on knee and 
opposite arm bent by head.  
  
  
3b. Obliques – contract abs, lift shoulders off 
floor and twist elbow towards opposite knee.   
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4a. Lower Abdominals – Reverse Crunch – 
start with legs raised and bent to 90 degrees at 
knee and hip joints.  
 
4b. Reverse Crunch – bring knees toward chest 
and hips can lift slightly off floor, return to 
start position.  
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APPENDIX B 
 
University of North Carolina at Chapel Hill 
Consent to Participate in a Research Study 
Adult Participants  
 
Consent Form Version Date: 26 October 2017 
IRB Study # 16-2427 
Title of Study: Feasibility Study of a Home-based Exercise Intervention Program for Patients 
with Metastatic Castration-Resistant Prostate Cancer Receiving Androgen-Deprivation Therapy 
(ADT)  
Principal Investigator: Erik Hanson 
Principal Investigator Department: Exercise and Sport Science 
Principal Investigator Phone number: (919) 962-0816 
Principal Investigator Email Address: edhanson@email.unc.edu  
Co-Investigators: Paul Godley, Young Whang, William Wood, Tracy Rose, Claudio Battaglini, 
Allison Deal, William Kim, Mary Dunn, Matthew Milowsky, Ethan Basch, Rhonda Bitting, 
Alexander Lucas, Stacy Harpe-Hall, Michelle Gordon 
_________________________________________________________________ 
 
What are some general things you should know about research studies? 
You are being asked to take part in a research study.  To join the study is voluntary. 
You may choose not to participate, or you may withdraw your consent to be in the study, for any 
reason, without penalty. 
 
Research studies are designed to obtain new knowledge. This new information may help people in 
the future.   You may not receive any direct benefit from being in the research study. There also 
may be risks to being in research studies. Deciding not to be in the study or leaving the study 
before it is done will not affect your relationship with the researcher, your health care provider, or 
the University of North Carolina-Chapel Hill (UNC-CH). If you are a patient with an illness, you 
do not have to be in the research study in order to receive health care. 
 
Details about this study are discussed below.  It is important that you understand this information 
so that you can make an informed choice about being in this research study.  
 
You will be given a copy of this consent form.  You should ask the researchers named above, or 
staff members who may assist them, any questions you have about this study at any time. 
 
What is the purpose of this study? 
The purpose of this research study is to evaluate the to evaluate the feasibility and effectiveness of 
 59 
 
a 12-week home-based exercise intervention to be conducted in men with metastatic castration 
resistant prostate cancer (mCRPC) receiving androgen deprivation therapy (ADT). We will 
examine if the home-based intervention can alter body composition (i.e., lean mass component), 
muscle strength, cardiovascular fitness, physical function, and quality of life. We will also explore 
the effects of the exercise training on biomarkers of inflammation-hormonal status (e.g., pro-
inflammatory cytokines, anti-inflammatory cytokines, and testosterone) and their potential 
association with changes in body composition and muscle, physical, and cardiovascular function.  
You are being asked to be in the study because you have metastatic castration resistant prostate 
cancer. 
To be eligible for the study, you need to be able to engage safely in moderate exercise as 
determined by your treating physician and you will also need access to a computer or a smart 
phone for syncing and uploading physical activity data. 
Are there any reasons you should not be in this study? 
You should not be in this study if you are currently 1) receiving chemotherapy, 2) if you have a 
history of bone fractures or any condition (such as bone, muscle, joint) that causes severe pain on 
exertion, 3) have active cardiovascular disease or any acute or chronic respiratory conditions that 
may make exercise unsafe, or 4) you are already performing exercise such as strength training, 
aerobic training, or walking on 3 or more days per week (or 90 minutes total per week). 
 
How many people will take part in this study? 
There will be approximately 30 people in this research study. 
 
How long will your part in this study last? 
Your time of involvement will be approximately 12-14 weeks. You will be asked to come to the 
Department of Exercise and Sport Science at the UNC-CH on two occasions, at the beginning of 
the study and after the 12-week exercise intervention. For each visit to the Department, you will 
be there approximately 2-3 hours.  
 
What will happen if you take part in the study? 
Below is a diagram illustrating the basic design of the study. It is a single arm study, so everyone 
in the study will be performing the exercise intervention.  
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All assessment-testing procedures will be done twice, once before a 12-week home-based 
exercise intervention and once afterwards. These procedures will require you do or undergo the 
following; 
 Body Composition determination to measure lean and fat mass and bone mineral 
density using dual-energy x-ray absorptiometry (DXA) scanner. Additionally, to 
look at muscle size and quality, you will have an ultra-sound of the quadriceps 
muscles of your leg. 
 Muscle strength, power, and endurance will be assessed using several different 
techniques. Upper and lower body muscle strength will be assessed on the chest 
press, knee extension, and leg press. This will involve lifting weights on a machine 
(you will be supervised). Muscle endurance will be determined using a repetitions 
test. Specifically, knee extensor muscle power will be assessed on an isokinetic 
dynamometer. This dynamometer device places you in a seated position with one 
of your legs attached to a lever arm. The use of this device will involve extending 
your leg as quickly as possible against a resistance load based on your maximal 
strength levels.  
 Cardiopulmonary function (aerobic fitness) will be assessed using a graded 
exercise test on a treadmill. You will begin the test walking slowly on the treadmill 
and every two minutes, the grade and speed of the treadmill will be increased in a 
progressive manner until fatigue occurs. Respiratory gases will be collected 
throughout the test and analyzed to determine oxygen utilization and carbon 
dioxide production. 
 Mobility functionality will be assessed using standard activities of daily living 
including the 6 meter walk test, the timed up and go test (you are timed to see how 
long it takes to rise from a chair, walk three meters, turn around, walk back to the 
chair, and sit down), 5 chair stands, stair climb tasks (you will be asked to climb a 
10-stair flight of stairs twice as fast as you can safely), and the 400m walk test. 
 Questionnaires that examine aspects of your “Quality of Life” and diet will need 
to be completed by you. Specifically, this will involve the following: 
o FACIT Fatigue scale is a short questionnaire that uses a rating scale that 
goes from 0 (no fatigue) to 10 (severe fatigue). It assesses the fatigue level 
in the last 7 days,  
o Hospital Anxiety and Depression (HADS) Questionnaire is a short 
questionnaire specific to depression.   
o Functional Assessment of Cancer Therapy-Prostate is a 3 page form 
assessment asking questions about daily activities and quality of life. 
o 24 Hour Dietary Recall where you will record all of your food and 
beverage intake over the 24-hour period prior to testing. 
 Blood samples will be obtained to examine hormone levels and markers of 
inflammation that may influence the response to the exercise intervention. You 
will provide 3-4 teaspoons of blood. These de-identified samples will be frozen 
and kept in the Department of Exercise and Sport Science until the end of the study 
for analysis. Any remaining samples will be discarded at the study’s end. 
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The exercise intervention will consist of a combination of aerobic (cardiovascular exercise) and 
strength training (emphasis of the intervention) ~3 times per week for 12 weeks with each session 
lasting ~1 hour. These sessions will take place at your home. You will be given an exercise training 
log to use for recording your exercise and you will receive an activity monitor to wear which will 
record heart rate, activity minutes, and calories burned throughout the study period. You will still 
be asked to record their exercise activity in their exercise training log. The duration of the aerobic 
exercise in each session per week will be 15-30 minutes. The strength training portion of each 
session will include different exercises. The upper body strength exercises will include lateral and 
front raises, wall or modified floor push-ups, chest press, bent row, arm curls, and triceps stretches. 
Lower body strength exercises will include chair squats, chair leg raises, hamstring curls, and calf 
raises. Core exercises will include bridge, crunches, reverse crunches, and obliques. Upper and 
lower body exercises will be done with elastic resistance bands. All exercises will be demonstrated 
to you during your initial exercise testing sessions. You will be also instructed on how to do 
stretching exercises after your aerobic training sessions. You will also be given an exercise training 
workbook that will include weekly exercise logs, your exercise training plan, and illustrations of 
resistance exercises and stretches. If you have any questions regarding the exercise training, you 
will be able to ask the research assistants that will be contacting you on a weekly basis to check 
on your progress with the exercise training.   
What are the possible benefits from being in this study? 
Research is designed to benefit society by gaining new knowledge. This study is trying to gain 
knowledge relative to prostate cancer, one of the most commonly diagnosed cancers among men 
and the second leading cause of cancer related deaths in men in the United States. Unlike cancers 
arising from other organs such as lung and pancreas cancer, the life expectancy for patients with 
advanced prostate cancer is measured in years. Thus, side effects of treatment that impact on 
quality of life are extremely important to consider in men with prostate cancer. The loss of 
testosterone (through androgen deprivation therapy (ADT)) is associated with many side effects 
including those related to negative changes in body composition (increase fat mass, loss of muscle 
mass), male menopause symptoms including hot flashes, loss of sexual drive, osteoporosis, high 
cholesterol, cardiovascular disease and diabetes, and severe fatigue. These side-effects, if not 
treated, may contribute to the development of other co-morbidities as well as lead to an inability 
to function at pre-cancer levels with the potential for a major impact on quality of life.  
 
The benefit to you from being in this study is that some of these side effects may be lessened after 
completing the exercise intervention. You will also obtain information about your current fitness 
levels and body composition. 
 
What are the possible risks or discomforts involved from being in this study? 
Potential risks from involvement in this study are as follows: 
 Exercise testing and training - In the unlikely event of injury during the fitness 
assessments portion of this study, such as muscle distensions and joint trauma, medical 
professionals on the research team will provide the appropriate care. Also, you will only 
be enrolled if your physician feels you are healthy enough to participate. 
 Bone fractures – There is a minimal risk of suffering a bone fracture through the 
performance of the exercise testing and home-based training. In the unlikely event of such 
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an occurrence during exercise testing, medical professionals on the research team will 
provide the appropriate care. Also, you will only be enrolled if your physician feels your 
bone mineral content (health) is appropriate for participation. 
 Ultrasound - There are no anticipated safety concerns associated with the use of ultrasound 
machine. 
 Blood draws - There is a minimal risk of bruising or infection from the blood draw 
procedure. To lessen this risk, only trained phlebotomists will be taking your blood. 
 DXA Scan - This research study involves exposure to radiation from 2 DXA scans. Please 
note that this radiation exposure is not necessary for your medical care and is for research 
purposes only. 
 
For comparison, the average person in the United States receives a radiation exposure of 
0.3 rem (or 300 mrem) per year from natural background sources, such as from the sun, 
outer space, and from radioactive materials that are found naturally in the earth’s air and 
soil. The dose that you will receive from participation in this research study is less than 
amount you receive from these natural sources in one year. 
 
The amount of radiation you will receive in this study has a minimal risk and is below the 
dose guideline established by The University of North Carolina Radiation Safety 
Committee for research subjects. 
 
There may be uncommon or previously unknown risks. You should report any problems to the 
researcher. 
 
What if we learn about new findings or information during the study?  
You will be given any new information gained during the course of the study that might affect 
your willingness to continue your participation.  
 
How will information about you be protected? 
The privacy and the confidentiality of your information are important. Procedures for protecting 
the privacy and confidentiality of such information are as follows:  
 Your information and records will be kept locked in a file cabinet, in a locked office.  
 Only members of the research team will have access to your information.  
 Only coded ID numbers will be used, and the linkage of identifiers (code and your name) 
will be kept in separate files such that your personal information is not readily identifiable.  
Participants will not be identified in any report or publication about this study. Although every 
effort will be made to keep research records private, there may be times when federal or state law 
requires the disclosure of such records, including personal information.  This is very unlikely, but 
if disclosure is ever required, the UNC-CH will take steps allowable by law to protect the privacy 
of personal information.  In some cases, your information in this research study could be reviewed 
by representatives of the University, research sponsors, or government agencies (for example, the 
FDA) for purposes such as quality control or safety. 
 
A copy of this consent form will go in to your medical record.  This will allow the doctors caring 
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for you to know what tests you may be receiving as a part of the study and know how to take care 
of you if you have other health problems or needs during the study. 
 
What will happen if you are injured by this research? 
All research involves a chance that something bad might happen to you.  This may include the risk 
of personal injury. In spite of all safety measures, you might develop a reaction or injury from 
being in this study. If such problems occur, the researchers will help you get medical care, but any 
costs for the medical care will be billed to you and/or your insurance company. The UNC-CH has 
not set aside funds to pay you for any such reactions or injuries, or for the related medical care. 
You do not give up any of your legal rights by signing this form. 
 
What if you want to stop before your part in the study is complete? 
You can withdraw from this study at any time, without penalty.  The investigators also have the 
right to stop your participation at any time. This could be because you have had an unexpected 
reaction, or have failed to follow instructions, or because the entire study has been stopped. 
 
Will you receive anything for being in this study? 
You will receive $100 per testing session ($200 total for completing all visits) to offset travel costs 
for this study. You are allowed to keep the wearable activity monitor and resistance bands at the 
end of the study. You will receive free parking at the Department of Exercise and Sport Science 
during your testing sessions. 
 
Will it cost you anything to be in this study? 
There are no costs to participate in the study. However, any additional transportation costs to attend 
the testing sessions that exceed $100 per visit are your responsibility. We will attempt to schedule 
testing sessions on the same day as your visits to the hospital whenever possible. 
 
What if you have questions about this study? 
You have the right to ask, and have answered, any questions you may have about this research. If 
you have questions about the study (including payments), complaints, concerns, or if a research-
related injury occurs, you should contact the researchers listed on the first page of this form. 
 
What if you have questions about your rights as a research participant? 
All research on human volunteers is reviewed by a committee that works to protect your rights and 
welfare.  If you have questions or concerns about your rights as a research subject, or if you would 
like to obtain information or offer input, you may contact the Institutional Review Board at 919-
966-3113 or by email to IRB_subjects@unc.edu. 
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Participant’s Agreement: 
 
I have read the information provided above.  I have asked all the questions I have at this time.  I 
voluntarily agree to participate in this research study. 
  
 
______________________________________________________ 
Signature of Research Participant 
 
____________________ 
Date 
 
______________________________________________________ 
Printed Name of Research Participant 
  
 
______________________________________________________ 
Signature of Research Team Member Obtaining Consent 
 
____________________ 
Date 
 
______________________________________________________ 
Printed Name of Research Team Member Obtaining Consent 
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APPENDIX C 
 
Week 1 
ACTIVITY  
MON TUES  WED  THURS FRI SAT  SUN 
Walking: 
Goal - 15 
mins,  2 
times this 
week. HR 
Target  
__________ 
(40-50% of 
heart rate 
reserve) 
Distance 
Walked:  
              
Stretches  (To be included with each exercise session – place a check mark on the days 
you stretch) – Hold stretches for 10-15 sec.  
1.  Neck                
2.  Overhead                
3.  Chest / 
Shoulders  
              
4.  Back                
5.  Scapula                
6.  Quads                
7.  
Hamstrings  
              
8.  Calves                
Strength Exercises: Goal – 1 set of each exercise for 12-15 repetitions 1 time this week. 
Record the # of reps completed on the last set in the box and the band color you used next 
to the exercise. The last set should be the hardest and where you complete the least number 
of reps. If you can complete all sets with 15 reps on the last set, increase resistance up to 
the next band.  
1.  Lateral 
Raises, 
Band:  
              
2.  Front 
Raises, 
Band:  
              
3.  Wall 
Pushup  
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4.  Bench / 
Floor 
Pushup  
              
6.  Chest 
Press, Band:  
              
7.  Bent 
Row, Band:  
              
8.  Arm 
Curls, Band:  
              
9.  Triceps 
Extension, 
Band:  
              
10, 11, or 
12. Chair 
Squat  
              
13 .  Chair 
Leg Raises, 
Band:  
              
14.  
Hamstring 
Curls, Band:  
              
 15.  Calf 
Raises  
              
 1.  Bridge                 
 2.  
Crunches  
              
3.  Oblique 
Crunch  
              
4.  Reverse 
Crunch   
              
  
Week 2 
ACTIVITY  
MON  TUES  WED  THURS  FRI  SAT  SUN  
Walking: 
Goal - 15 
mins,  2 
times this 
week. HR 
Target  
__________ 
(40-50% of 
heart rate 
reserve) 
Distance 
Walked:  
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Stretches  (To be included with each exercise session – place a check mark on the days 
you stretch) – Hold stretches for 10-15 sec.  
1.  Neck                
2.  Overhead                
3.  Chest / 
Shoulders  
              
4.  Back                
5.  Scapula                
6.  Quads                
7.  
Hamstrings  
              
8.  Calves                
Strength Exercises: Goal – 1 set of each exercise for 12-15 repetitions 2 times this 
week. Record the # of reps completed on the last set in the box and the band color you used 
next to the exercise. The last set should be the hardest and where you complete the least 
number of reps. If you can complete all sets with 15 reps on the last set, increase resistance 
up to the next band.  
1.  Lateral 
Raises, 
Band:  
              
2.  Front 
Raises, 
Band:  
              
3.  Wall 
Pushup  
              
4.  Bench / 
Floor 
Pushup  
              
6.  Chest 
Press, Band:  
              
7.  Bent 
Row, Band:  
              
8.  Arm 
Curls, Band:  
              
9.  Triceps 
Extension, 
Band:  
              
10, 11, or 
12. Chair 
Squat  
              
13 .  Chair 
Leg Raises, 
Band:  
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14.  
Hamstring 
Curls, Band:  
              
 15.  Calf 
Raises  
              
 1.  Bridge                 
 2.  
Crunches  
              
3.  Oblique 
Crunch  
              
4.  Reverse 
Crunch   
              
  
Week 3 
ACTIVITY  
MON  TUES  WED  THURS  FRI  SAT  SUN  
Walking: 
Goal - 20 
mins,  3 
times this 
week. HR 
Target  
__________ 
(50-60% of 
heart rate 
reserve) 
Distance 
Walked:  
              
Stretches  (To be included with each exercise session – place a check mark on the days 
you stretch) – Hold stretches for 10-15 sec.  
1.  Neck                
2.  Overhead                
3.  Chest / 
Shoulders  
              
4.  Back                
5.  Scapula                
6.  Quads                
7.  
Hamstrings  
              
8.  Calves                
Strength Exercises: Goal – 2 sets of each exercise for 12-15 repetitions 2 times this 
week. Record the # of reps completed on the last set in the box and the band color you 
used next to the exercise. The last set should be the hardest and where you complete the 
least number of reps. If you can complete all sets with 15 reps on the last set, increase 
resistance up to the next band.  
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1.  Lateral 
Raises, Band:  
              
2.  Front 
Raises, Band:  
              
3.  Wall 
Pushup  
              
4.  Bench / 
Floor Pushup  
              
6.  Chest 
Press, Band:  
              
7.  Bent Row, 
Band:  
              
8.  Arm 
Curls, Band:  
              
9.  Triceps 
Extension, 
Band:  
              
10, 11, or 12. 
Chair Squat  
              
13 .  Chair 
Leg Raises, 
Band:  
              
14.  
Hamstring 
Curls, Band:  
              
 15.  Calf 
Raises  
              
 1.  Bridge                 
 2.  Crunches                
3.  Oblique 
Crunch  
              
4.  Reverse 
Crunch   
              
  
Week 4 
ACTIVITY  
MON  TUES  WED  THURS  FRI SAT  SUN  
Walking: 
Goal - 30 
mins,  4 times 
this week. HR 
Target  
__________ 
(50-60% of 
heart rate 
reserve) 
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Distance 
Walked:  
Stretches  (To be included with each exercise session – place a check mark on the days 
you stretch) – Hold stretches for 10-15 sec.  
1.  Neck                
2.  Overhead                
3.  Chest / 
Shoulders  
              
4.  Back                
5.  Scapula                
6.  Quads                
7.  Hamstrings                
8.  Calves                
Strength Exercises: Goal – 2 set of each exercise for 12-15 repetitions 3 times this 
week. Record the # of reps completed on the last set in the box and the band color you used 
next to the exercise. The last set should be the hardest and where you complete the least 
number of reps. If you can complete all sets with 15 reps on the last set, increase resistance 
up to the next band.  
1.  Lateral 
Raises, Band:  
              
2.  Front 
Raises, Band:  
              
3.  Wall 
Pushup  
              
4.  Bench / 
Floor Pushup  
              
6.  Chest 
Press, Band:  
              
7.  Bent Row, 
Band:  
              
8.  Arm Curls, 
Band:  
              
9.  Triceps 
Extension, 
Band:  
              
10, 11, or 12. 
Chair Squat  
              
13 .  Chair 
Leg Raises, 
Band:  
              
14.  Hamstring 
Curls, Band:  
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 15.  Calf 
Raises  
              
 1.  Bridge                 
 2.  Crunches                
3.  Oblique 
Crunch  
              
4.  Reverse 
Crunch   
              
  
Week 5 
ACTIVITY  
MON  TUES  WED  THURS  FRI  SAT  SUN  
Walking: Goal - 
22 mins,  4 times 
this week. HR 
Target  
__________ (50-
60% of heart rate 
reserve) Distance 
Walked:  
              
Stretches  (To be included with each exercise session – place a check mark on the days you 
stretch) – Hold stretches for 10-15 sec.  
1.  Neck                
2.  Overhead                
3.  Chest / 
Shoulders  
              
4.  Back                
5.  Scapula                
6.  Quads                
7.  Hamstrings                
8.  Calves                
Strength Exercises: Goal – 2 sets of each exercise for 12-15 repetitions 3 times this 
week. Record the # of reps completed on the last set in the box and the band color you used 
next to the exercise. The last set should be the hardest and where you complete the least 
number of reps. If you can complete all sets with 15 reps on the last set, increase resistance 
up to the next band.  
1.  Lateral Raises, 
Band:  
              
2.  Front Raises, 
Band:  
              
3.  Wall Pushup                
4.  Bench / Floor 
Pushup  
              
6.  Chest Press, 
Band:  
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7.  Bent Row, 
Band:  
              
8.  Arm Curls, 
Band:  
              
9.  Triceps 
Extension, Band:  
              
10, 11, or 12. 
Chair Squat  
              
13 .  Chair Leg 
Raises, Band:  
              
14.  Hamstring 
Curls, Band:  
              
 15.  Calf Raises                
 1.  Bridge                 
 2.  Crunches                
3.  Oblique 
Crunch  
              
4.  Reverse 
Crunch   
              
  
Week 6 
ACTIVITY  
MON  TUES  WED  THURS  FRI SAT  SUN  
Walking: Goal - 
22 mins.  4 times 
this week. HR 
Target  
__________ (50-
60% of heart rate 
reserve) Distance 
Walked:  
              
Stretches  (To be included with each exercise session – place a check mark on the days you 
stretch) – Hold stretches for 10-15 sec.  
1.  Neck                
2.  Overhead                
3.  Chest / 
Shoulders  
              
4.  Back                
5.  Scapula                
6.  Quads                
7.  Hamstrings                
8.  Calves                
Strength Exercises: Goal – 2 sets of each exercise for 12-15 repetitions 3 times this 
week. Record the # of reps completed on the last set in the box and the band color you used 
next to the exercise. The last set should be the hardest and where you complete the least 
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number of reps. If you can complete all sets with 15 reps on the last set, increase resistance 
up to the next band.  
1.  Lateral Raises, 
Band:  
              
2.  Front Raises, 
Band:  
              
3.  Wall Pushup                
4.  Bench / Floor 
Pushup  
              
6.  Chest Press, 
Band:  
              
7.  Bent Row, 
Band:  
              
8.  Arm Curls, 
Band:  
              
9.  Triceps 
Extension, Band:  
              
10, 11, or 12. 
Chair Squat  
              
13 .  Chair Leg 
Raises, Band:  
              
14.  Hamstring 
Curls, Band:  
              
 15.  Calf Raises                
 1.  Bridge                 
 2.  Crunches                
3.  Oblique 
Crunch  
              
4.  Reverse 
Crunch   
              
  
 
Week 7 
ACTIVITY  
MON  TUES  WED  THURS FRI SAT  SUN  
Walking: Goal 
- 25 mins.  4 
times this 
week. HR 
Target  
__________ 
(55-65% of 
heart rate 
reserve) 
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Distance 
Walked:  
Stretches  (To be included with each exercise session – place a check mark on the days you 
stretch) – Hold stretches for 10-15 sec.  
1.  Neck                
2.  Overhead                
3.  Chest / 
Shoulders  
              
4.  Back                
5.  Scapula                
6.  Quads                
7.  Hamstrings                
8.  Calves                
Strength Exercises: Goal – 2 sets of each exercise for 12-15 repetitions 3 times this 
week. Record the # of reps completed on the last set in the box and the band color you used 
next to the exercise. The last set should be the hardest and where you complete the least 
number of reps. If you can complete all sets with 15 reps on the last set, increase resistance 
up to the next band.  
1.  Lateral 
Raises, Band:  
              
2.  Front 
Raises, Band:  
              
3.  Wall 
Pushup  
              
4.  Bench / 
Floor Pushup  
              
6.  Chest Press, 
Band:  
              
7.  Bent Row, 
Band:  
              
8.  Arm Curls, 
Band:  
              
9.  Triceps 
Extension, 
Band:  
              
10, 11, or 12. 
Chair Squat  
              
13 .  Chair Leg 
Raises, Band:  
              
14.  Hamstring 
Curls, Band:  
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 15.  Calf 
Raises  
              
 1.  Bridge                 
 2.  Crunches                
3.  Oblique 
Crunch  
              
4.  Reverse 
Crunch   
              
  
Week 8 
ACTIVITY  
MON  TUES  WED  THURS  FRI  SAT  SUN  
Walking: 
Goal - 25 
mins,  4 times 
this week. HR 
Target  
__________ 
(55-65% of 
heart rate 
reserve) 
Distance 
Walked:  
              
Stretches  (To be included with each exercise session – place a check mark on the days you 
stretch) – Hold stretches for 10-15 sec.  
1.  Neck                
2.  Overhead                
3.  Chest / 
Shoulders  
              
4.  Back                
5.  Scapula                
6.  Quads                
7.  Hamstrings                
8.  Calves                
Strength Exercises: Goal – 2 sets of each exercise for 12-15 repetitions 3 time this week. 
Record the # of reps completed on the last set in the box and the band color you used next to 
the exercise. The last set should be the hardest and where you complete the least number of 
reps. If you can complete all sets with 15 reps on the last set, increase resistance up to the 
next band.  
1.  Lateral 
Raises, Band:  
              
2.  Front 
Raises, Band:  
              
3.  Wall 
Pushup  
              
 76 
 
4.  Bench / 
Floor Pushup  
              
6.  Chest Press, 
Band:  
              
7.  Bent Row, 
Band:  
              
8.  Arm Curls, 
Band:  
              
9.  Triceps 
Extension, 
Band:  
              
10, 11, or 12. 
Chair Squat  
              
13 .  Chair Leg 
Raises, Band:  
              
14.  Hamstring 
Curls, Band:  
              
 15.  Calf 
Raises  
              
 1.  Bridge                 
 2.  Crunches                
3.  Oblique 
Crunch  
              
4.  Reverse 
Crunch   
              
  
 
 
 
Week 9 
ACTIVITY  
MON  TUES  WED  THURS  FRI SAT  SUN  
Walking: 
Goal - 25 
mins,  4 times 
this week. HR 
Target  
__________ 
(55-65% of 
heart rate 
reserve) 
Distance 
Walked:  
              
Stretches  (To be included with each exercise session – place a check mark on the days you 
stretch) – Hold stretches for 10-15 sec.  
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1.  Neck                
2.  Overhead                
3.  Chest / 
Shoulders  
              
4.  Back                
5.  Scapula                
6.  Quads                
7.  Hamstrings                
8.  Calves                
Strength Exercises: Goal – 2 sets of each exercise for 12-15 repetitions 3 time this week. 
Record the # of reps completed on the last set in the box and the band color you used next to 
the exercise. The last set should be the hardest and where you complete the least number of 
reps. If you can complete all sets with 15 reps on the last set, increase resistance up to the 
next band.  
1.  Lateral 
Raises, Band:  
              
2.  Front 
Raises, Band:  
              
3.  Wall 
Pushup  
              
4.  Bench / 
Floor Pushup  
              
6.  Chest 
Press, Band:  
              
7.  Bent Row, 
Band:  
              
8.  Arm Curls, 
Band:  
              
9.  Triceps 
Extension, 
Band:  
              
10, 11, or 12. 
Chair Squat  
              
13 .  Chair Leg 
Raises, Band:  
              
14.  Hamstring 
Curls, Band:  
              
 15.  Calf 
Raises  
              
 1.  Bridge                 
 2.  Crunches                
3.  Oblique 
Crunch  
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4.  Reverse 
Crunch   
              
  
Week 10 
ACTIVITY  
MON TUES WED  THURS  FRI  SAT  SUN  
Walking: 
Goal - 30 
mins,  4 
times this 
week. HR 
Target  
__________ 
(55-65% of 
heart rate 
reserve) 
Distance 
Walked:  
              
Stretches  (To be included with each exercise session – place a check mark on the days you 
stretch) – Hold stretches for 10-15 sec.  
1.  Neck                
2.  Overhead                
3.  Chest / 
Shoulders  
              
4.  Back                
5.  Scapula                
6.  Quads                
7.  
Hamstrings  
              
8.  Calves                
Strength Exercises: Goal – 3 sets of each exercise for 12-15 repetitions 3 times this 
week. Record the # of reps completed on the last set in the box and the band color you used 
next to the exercise. The last set should be the hardest and where you complete the least 
number of reps. If you can complete all sets with 15 reps on the last set, increase resistance 
up to the next band.  
1.  Lateral 
Raises, 
Band:  
              
2.  Front 
Raises, 
Band:  
              
3.  Wall 
Pushup  
              
4.  Bench / 
Floor 
Pushup  
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6.  Chest 
Press, Band:  
              
7.  Bent 
Row, Band:  
              
8.  Arm 
Curls, Band:  
              
9.  Triceps 
Extension, 
Band:  
              
10, 11, or 
12. Chair 
Squat  
              
13 .  Chair 
Leg Raises, 
Band:  
              
14.  
Hamstring 
Curls, Band:  
              
 15.  Calf 
Raises  
              
 1.  Bridge                 
 2.  
Crunches  
              
3.  Oblique 
Crunch  
              
4.  Reverse 
Crunch   
              
  
 
Week 11 
ACTIVITY  
MON  TUES  WED  THURS  FRI  SAT SUN 
Walking: 
Goal - 30 
mins,  4 
times this 
week. HR 
Target  
__________ 
(55-65% of 
heart rate 
reserve) 
Distance 
Walked:  
              
Stretches  (To be included with each exercise session – place a check mark on the days you 
stretch) – Hold stretches for 10-15 sec.  
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1.  Neck                
2.  Overhead                
3.  Chest / 
Shoulders  
              
4.  Back                
5.  Scapula                
6.  Quads                
7.  
Hamstrings  
              
8.  Calves                
Strength Exercises: Goal – 3 sets of each exercise for 12-15 repetitions 3 times this week. 
Record the # of reps completed on the last set in the box and the band color you used next to 
the exercise. The last set should be the hardest and where you complete the least number of 
reps. If you can complete all sets with 15 reps on the last set, increase resistance up to the next 
band.  
1.  Lateral 
Raises, 
Band:  
              
2.  Front 
Raises, 
Band:  
              
3.  Wall 
Pushup  
              
4.  Bench / 
Floor 
Pushup  
              
6.  Chest 
Press, Band:  
              
7.  Bent 
Row, Band:  
              
8.  Arm 
Curls, Band:  
              
9.  Triceps 
Extension, 
Band:  
              
10, 11, or 
12. Chair 
Squat  
              
13 .  Chair 
Leg Raises, 
Band:  
              
14.  
Hamstring 
Curls, Band:  
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 15.  Calf 
Raises  
              
 1.  Bridge                 
 2.  
Crunches  
              
3.  Oblique 
Crunch  
              
4.  Reverse 
Crunch   
              
  
Week 12 
ACTIVITY  
MON  TUES  WED  THURS  FRI  SAT  SUN  
Walking: Goal - 
30 mins,  4 times 
this week. HR 
Target  
__________ (55-
65% of heart rate 
reserve) Distance 
Walked:  
              
Stretches  (To be included with each exercise session – place a check mark on the days you 
stretch) – Hold stretches for 10-15 sec.  
1.  Neck                
2.  Overhead                
3.  Chest / 
Shoulders  
              
4.  Back                
5.  Scapula                
6.  Quads                
7.  Hamstrings                
8.  Calves                
Strength Exercises: Goal – 3 sets of each exercise for 12-15 repetitions 3 times this 
week. Record the # of reps completed on the last set in the box and the band color you used 
next to the exercise. The last set should be the hardest and where you complete the least 
number of reps. If you can complete all sets with 15 reps on the last set, increase resistance 
up to the next band.  
1.  Lateral Raises, 
Band:  
              
2.  Front Raises, 
Band:  
              
3.  Wall Pushup                
4.  Bench / Floor 
Pushup  
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6.  Chest Press, 
Band:  
              
7.  Bent Row, 
Band:  
              
8.  Arm Curls, 
Band:  
              
9.  Triceps 
Extension, Band:  
              
10, 11, or 12. 
Chair Squat  
              
13 .  Chair Leg 
Raises, Band:  
              
14.  Hamstring 
Curls, Band:  
              
 15.  Calf Raises                
 1.  Bridge                 
 2.  Crunches                
3.  Oblique 
Crunch  
              
4.  Reverse 
Crunch   
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APPENDIX D 
 
Weekly Follow-Up Form 
 
Participant: 
 
Date, Week of Intervention: 
 
 
Exercise Information (Day, Time): 
 
Band Walk
 
 
 
 
 
Notes: 
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APPENDIX E 
 
Garmin Data Extraction Instructions: 
1. Log in to Garmin Connect account. 
2. Go to “Daily Summary.” 
3. Record times in which session criteria are met. 
 
Session Criteria: 
1. Elevated heart rate combined with increase in step count 
2. Elevations in heart rate and step count must be sustained for at least half of the duration 
of a walking session for the appropriate week of the program
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APPENDIX F 
 
Garmin Account Setup Procedure: 
1) Create a gmail account.  
- Go to https://accounts.google.com/SignUp?hl=en and fill in the information 
- We have been using uncexss0xx@gmail.com where “xx” is the subject number. 
- It is not important to have the participant’s information correct for the gmail account, 
as only we will access it and it will not affect the data in any way. 
2) Create a Garmin Connect account that is tied to that gmail account. 
- Go to https://connect.garmin.com/en-US/signin and click “create one” 
- Create an account using the gmail address that you just created. Agree to the terms 
and conditions and click “create account.” 
- Select “activity tracking” and “fitness” to display on the dashboard. 
- Go to “account settings” and update their “user settings” to give them an accurate 
height and weight whenever these are known 
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3) Sync the watch to the new Garmin account. 
- Download Garmin Express: https://www.garmin.com/en-US/software/express  
- Open Garmin Express once it is finished downloading 
- Open the watch from the box. Turn it on and set the appropriate time and date; do not 
connect with Bluetooth. Connect the watch to the charging cable and plug USB end 
of the cable into your computer. 
- On your computer in the Garmin Express app, click “add device.” Allow the 
computer to search for and find the watch, and click “add device.” 
- Register the watch using the gmail address used to make the Garmin Connect 
account. Follow prompts on screen. The watch will now be connected to the Garmin 
Connect Account that you created. 
- Go to Garmin Connect https://connect.garmin.com/en-US/signin and sign in using the 
account information you used earlier. In the upper right hand corner, click the watch 
icon. It should now say “vivosmart HR” (or whatever you nicknamed the watch if 
you did so). This website is where their information will be available whenever they 
sync the watch to their account. 
- Update the watch if necessary. 
4) Ensure participant is syncing to correct account on baseline testing day 
- They can use either Garmin Connect their smartphone or Garmin Express on their 
computer. 
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- If they use their phone, download the Garmin Connect app. Sign them in using the 
account information associated with the watch they are being given. Make sure 
Bluetooth is turned on. On the watch, click the menu button on the side of the watch, 
and scroll to the Bluetooth icon. Press “pair smartphone.” On their phone, click “add 
device.” Complete the sync process, and data will periodically sync as long as the 
Bluetooth connection is maintained. 
- If they elect to use their computer, they will need to download Garmin Express on 
their computer and add the device in the same way as described above. The watch 
will already be registered to the appropriate account, so they will stop after clicking 
“add device.” The participant will need to periodically connect the charging cable 
into the computer and open the Garmin Express App. In the app, they can click on the 
picture of their watch, and then press “sync.” The data will sync and be available on 
Garmin Connect. 
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